NewsAmgen "outperform," target price reduced
24.04.09 - Credit Suisse
NEW YORK, April 24 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Amgen Inc (AMGN). The target price has been reduced from $68 to $62.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren